POC1A and neoplasm: Subsequently, we examined the association between POC1A and several anti‐tumour medications, encompassing bortezomib, cisplatin, docetaxel, entinostat, erlotinib, gefitinib, obatoclax mesylate, paclitaxel, savolitinib, temozolomide, vincristine and vinorelbine.